The proton pump inhibitor pantoprazole effectively improves the liver function (ALT, albumin, T bilirubin, D bilirubin and AFP) in rats with precancerous lesions and the microstructure characteristics of the liver, reducing the exosomal abundance in the HCC tissues and serum of the rat liver. Here, AFP is linked to hepatocellular carcinoma.